PXS.L
Provexis plc [PXS.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
PXS.L Stock Summary
Top 10 Correlated Stocks
PXS.L
In the News
PXS.L Financial details
Company Rating
Sell
Market Cap
15.56M
Income
-746.43K
Revenue
992.42K
Book val./share
0
Cash/share
0
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
27 Sep 2024
P/E
-40.28
Forward P/E
-
PEG
-2.01
P/S
44.65
P/B
13.05
P/C
-
P/FCF
-33.43
Quick Ratio
2.01
Current Ratio
4.49
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
100%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-7.79%
Revenue last 5Y
3.89%
Revenue Q/Q
84.06%
EPS Q/Q
-
-
-
-
-
SMA20
1.56%
SMA50
-5.8%
SMA100
30%
Inst Own
-
Inst Trans
-
ROA
-46%
ROE
-29%
ROC
-0.64%
Gross Margin
76%
Oper. Margin
-108%
Profit Margin
-99%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.413-0.9
52W High
-
52W Low
-
RSI
52.72
Rel Volume
0.05
Avg Volume
818.86K
Volume
37.73K
Perf Week
-3.7%
Perf Month
-10.34%
Perf Quarter
7.79%
Perf Half Y
8.33%
-
-
-
-
Beta
1.19
-
-
Volatility
0.01%, 0.02%
Prev Close
0%
Price
0.65
Change
-7.14%
PXS.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
| Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 5.12M | 9.03M | 17.98M | 18.79M | 17.51M | |
| Enterprise value | 4.8M | 8.73M | 16.9M | 17.93M | 17.13M | |
| P/E ratio | -9.99 | -22.22 | -52.72 | -83.8 | -45.46 | |
| Price to sales ratio | 15.9 | 25.94 | 35.58 | 44.1 | 44.91 | |
| POCF ratio | -13.34 | -26.97 | -68.6 | -88 | -33.69 | |
| PFCF ratio | -13.34 | -26.97 | -68.54 | -87.9 | -33.69 | |
| P/B Ratio | 6.28 | 11.08 | 10.86 | 12.54 | 14.72 | |
| PTB ratio | 6.28 | 11.08 | 10.86 | 12.54 | 14.72 | |
| EV to sales | 14.89 | 25.1 | 33.45 | 42.07 | 43.94 | |
| Enterprise value over EBITDA | 229.85 | -19.83 | -48.04 | -60.52 | -39.16 | |
| EV to operating cash flow | -12.49 | -26.1 | -64.49 | -83.96 | -32.96 | |
| EV to free cash flow | -12.49 | -26.1 | -64.43 | -83.86 | -32.96 | |
| Earnings yield | -0.1 | -0.05 | -0.02 | -0.01 | -0.02 | |
| Free cash flow yield | -0.07 | -0.04 | -0.01 | -0.01 | -0.03 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | -15.6 | 0.66 | 3.06 | 2.92 | 0.87 | |
| Current ratio | 3.75 | 3.12 | 8.58 | 7.14 | 4.49 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.75 | 0.82 | 0.77 | 0.95 | 1.35 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 1.73 | 1.31 | 0.92 | 0.9 | 1.09 | |
| Research and developement to revenue | 0.71 | 0.72 | 0.6 | 0.59 | 0.61 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0.46 | 0.3 | 0.27 | 0.16 | 0.1 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | -0.63 | -0.53 | -0.21 | -0.16 | -0.34 | |
| Return on tangible assets | -1.11 | -0.87 | -0.26 | -0.2 | -0.46 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 338.89K | 318.68K | 1.14M | 969.08K | 657.66K | |
| Tangible asset value | 338.89K | 318.68K | 1.14M | 969.08K | 657.66K | |
| Net current asset value | 338.89K | 318.68K | 1.14M | 969.08K | 657.66K | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 2.37K | 85.38K | 161.11K | 166.1K | 158.19K | |
| Average payables | 32.73K | 29.21K | 21.4K | 22.6K | 22.11K | |
| Average inventory | 28.19K | 27.98K | 35.33K | 73.19K | 206.8K | |
| Days sales outstanding | 3.89 | 175.55 | 111.87 | 151.86 | 130.19 | |
| Days payables outstanding | 266.71 | 227.44 | 152.3 | 195.52 | 74.58 | |
| Days of inventory on hand | 338.66 | 102.86 | 449.98 | 679.11 | 1.25K | |
| Receivables turnover | 93.93 | 2.08 | 3.26 | 2.4 | 2.8 | |
| Payables turnover | 1.37 | 1.6 | 2.4 | 1.87 | 4.89 | |
| Inventory turnover | 1.08 | 3.55 | 0.81 | 0.54 | 0.29 | |
| ROE | -0.63 | -0.5 | -0.21 | -0.15 | -0.32 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-09-30 for Q2
| Metric | History | 2021-09-30 | 2022-03-31 | 2022-09-30 | 2023-03-31 | 2023-09-30 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 17.69M | 18.79M | 16.06M | 17.52M | 13.37M | |
| Enterprise value | 16.7M | 17.93M | 15.32M | 17.14M | 13.05M | |
| P/E ratio | -33.97 | -49.93 | -25.78 | -19.09 | -12.52 | |
| Price to sales ratio | 83.75 | 87.42 | 89.56 | 83.22 | 34.51 | |
| POCF ratio | -184.71 | -159.55 | -104.03 | -47.95 | -221.77 | |
| PFCF ratio | -184.71 | -159.55 | -104.03 | -47.95 | -221.77 | |
| P/B Ratio | 11.38 | 12.54 | 11.56 | 14.73 | 13.61 | |
| PTB ratio | 11.38 | 12.54 | 11.56 | 14.73 | 13.61 | |
| EV to sales | 79.1 | 83.4 | 85.41 | 81.41 | 33.69 | |
| Enterprise value over EBITDA | -115.02 | -116.43 | -88.04 | -69.42 | -47.24 | |
| EV to operating cash flow | -174.46 | -152.21 | -99.21 | -46.91 | -216.49 | |
| EV to free cash flow | -174.46 | -152.21 | -99.21 | -46.91 | -216.49 | |
| Earnings yield | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | |
| Free cash flow yield | -0.01 | -0.01 | -0.01 | -0.02 | 0 | |
| Debt to equity | 0 | 0 | 0 | 0 | 0 | |
| Debt to assets | 0 | 0 | 0 | 0 | 0 | |
| Net debt to EBITDA | 6.76 | 5.61 | 4.28 | 1.54 | 1.15 | |
| Current ratio | 6.94 | 7.14 | 6.62 | 4.49 | 2.41 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0.74 | 1.25 | 0.99 | 1.59 | 0.23 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.79 | 1.01 | 1.09 | 1.1 | 0.62 | |
| Research and developement to revenue | 0.67 | 0.51 | 0.6 | 0.62 | 0.36 | |
| Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0.13 | 0.18 | 0.06 | 0.14 | 0.16 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | -0.09 | -0.06 | -0.11 | -0.19 | -0.27 | |
| Return on tangible assets | -0.11 | -0.08 | -0.15 | -0.27 | -0.35 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 1.03M | 969.08K | 857.86K | 657.66K | 451.08K | |
| Tangible asset value | 1.03M | 969.08K | 857.86K | 657.66K | 451.08K | |
| Net current asset value | 1.03M | 969.08K | 857.86K | 657.66K | 451.08K | |
| Invested capital | 0 | 0 | 0 | 0 | 0 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 0 | 0 | 0 | 0 | |
| Average inventory | 0 | 0 | 0 | 0 | 0 | |
| Days sales outstanding | 46.43 | 74.23 | 101.39 | 59.45 | 70.93 | |
| Days payables outstanding | 639.48 | 650.96 | 514.24 | 246.49 | 114.91 | |
| Days of inventory on hand | 398.88 | 353.73 | 215.36 | 429.01 | 52.54 | |
| Receivables turnover | 1.94 | 1.21 | 0.89 | 1.51 | 1.27 | |
| Payables turnover | 0.14 | 0.14 | 0.18 | 0.37 | 0.78 | |
| Inventory turnover | 0.23 | 0.25 | 0.42 | 0.21 | 1.71 | |
| ROE | -0.08 | -0.06 | -0.11 | -0.19 | -0.27 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
PXS.L Frequently Asked Questions
What is Provexis plc stock symbol ?
Provexis plc is a GB stock and trading under the symbol PXS.L
What is Provexis plc stock quote today ?
Provexis plc stock price is $0.65 today.
Is Provexis plc stock public?
Yes, Provexis plc is a publicly traded company.
Company Profile
- Volume Average 818.86K
- Market Capitalization 15.56M
- Employee 2
- CEO Mr. Ian Ford BA (Hons) ACA, F.C.A.
- Headquarters Reading,GB
- IPO Date 2004-06-28
-
Website
https://www.provexis.com 
Provexis plc, together with its subsidiaries, develops, licenses, and markets functional foods, medical foods, and dietary supplements worldwide. Its products include Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke. The company's syrup and powder versions of Fruitflow are used in foods, beverages, and dietary supplement formats. It also offers Fruitflow + Omega-3, a supplement in capsule form that supports healthy blood flow and normal heart function. Provexis plc has a collaboration agreement with By-Health Co., Ltd. The company offers its products through retail stores, as well as online. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom.
